Natus Sensory Announces the US Launch of ICS® Dizcovery VNG at AAA 2025

Natus Sensory, the world leader in hearing and balance diagnostic systems, announces the official US launch of the ICS® Dizcovery VNG today at the American Academy of Audiology's Annual Convention and Expo in New Orleans, LA. An addition to the well-known and respected portfolio of ICS balance-assessment products, the ICS Dizcovery is the first-ever videonystagmography (VNG) solution to offer all-in-one, plug-and-play goggles that work with a unified diagnostic software platform for comprehensive vestibular assessment, including VNG and caloric testing, while also supporting video head impulse testing (vHIT) when used with Natus Sensory’s ICS® Impulse solution and Otosuite® Vestibular software. A uniquely portable and precise tool, it revolutionizes workflows, breaks down data silos, and reduces opportunities for error.

Redefining Balance Assessment with Unmatched Flexibility and Performance

The ICS Dizcovery introduces a new era of vestibular diagnostics, providing greater clinical flexibility and efficiency while eliminating the need for bulky, external hardware such as a light bar. Designed with clinicians in mind, it simplifies assessments, reduces setup complexity, and saves time with an intuitive, plug-and-play system.

Key benefits of the ICS Dizcovery include:

• Unmatched portability – Perform balance assessments anywhere without being restricted by external equipment such as a light bar or a monitor.
• Integrated Freedom™ Laser for smooth stimulus presentation – Eliminates the need for a separate light bar, improving accuracy and reducing space constraints.
• Precision optics and high-resolution video – Capture clear, reliable eye-tracking data for more accurate diagnoses.
• Unified software experience – Seamlessly integrates with Otosuite Vestibular, providing a holistic approach to balance testing.

A true game-changer in vestibular diagnostics

“We are thrilled to bring ICS Dizcovery to the US market and introduce a true game-changer in vestibular diagnostics,” said Natus Sensory CEO, Peter Reimer. “Clinicians have long faced challenges with complex, fragmented systems that slow down assessments and increase room for error. With ICS Dizcovery, we are delivering a smarter, more efficient solution that frees them from unnecessary hardware and optimizes their workflow.”

Peter Reimer continued, “Our goal at Natus Sensory is to empower clinicians with the most advanced, reliable, and easy-to-use diagnostic tools available. ICS Dizcovery represents our commitment to innovation, ensuring that balance assessments are more precise, efficient, and accessible than ever before.”

Experience ICS Dizcovery at AAA 2025

Natus Sensory will be demonstrating ICS Dizcovery live at its booth #401 at AAA 2025. Attendees can experience firsthand how ICS Dizcovery enhances clinical workflows and improves diagnostic confidence.

The ICS Dizcovery is available for immediate shipping in the United States, providing clinicians with a next-generation vestibular testing solution that redefines efficiency, accuracy, and convenience.

For more information, visit natus.com/sensory/dizcovery.

About Natus Sensory

Natus Sensory is a global leader in solutions for screening and assessing hearing, balance, and vision, making a real difference in patient care. With a long history of groundbreaking innovations, the company is driven by a commitment to improving outcomes for patients and enhancing the daily work of healthcare professionals.

At the core of Natus Sensory's innovation process is a deep dedication to listening to the needs of clinicians, ensuring that every product is designed with real-world clinical challenges in mind. The company’s premium solutions are recognized for their ease of use, stability, and demonstrated safety. In addition to high-quality products, Natus Sensory provides comprehensive training and ongoing education, empowering healthcare professionals with the knowledge and support they need.

With a strong focus on service and support, Natus Sensory ensures low lifetime costs and reliable equipment performance, delivering value when it matters most—for both clinicians and their patients.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250326524689/en/

We are thrilled to bring ICS Dizcovery to the US market and introduce a true game-changer in vestibular diagnostics.